These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6926926)

  • 21. Technology transfer at US universities: seeking public benefit from the results of basic research.
    Goodwin CD
    Technol Health Care; 1996 Sep; 4(3):323-30. PubMed ID: 8931243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The President vetoes stricter congressional oversight of NIH.
    Iglehart JK
    N Engl J Med; 1984 Nov; 311(22):1452-6. PubMed ID: 6493311
    [No Abstract]   [Full Text] [Related]  

  • 23. View from the Nation's Capital.
    Romansky MA
    J Clin Psychopharmacol; 1984 Feb; 4(1):52-4. PubMed ID: 6096407
    [No Abstract]   [Full Text] [Related]  

  • 24. The growing family of NIH institutes.
    Randerath K
    Science; 2001 Jun; 292(5523):1835-6. PubMed ID: 11398826
    [No Abstract]   [Full Text] [Related]  

  • 25. View from the Nation's Capital.
    Romansky MA
    J Clin Psychopharmacol; 1984 Jun; 4(3):161-2. PubMed ID: 6096408
    [No Abstract]   [Full Text] [Related]  

  • 26. National Institutes of Health. A government niche for translational medicine and drug development.
    Kaiser J
    Science; 2010 Dec; 330(6010):1462-3. PubMed ID: 21148358
    [No Abstract]   [Full Text] [Related]  

  • 27. Capitol report.
    Baxter MD
    Oncologist; 2001; 6(4):386-7. PubMed ID: 11524558
    [No Abstract]   [Full Text] [Related]  

  • 28. Increase competition to stabilize drug prices.
    Miller HI
    Science; 2001 Jul; 293(5528):213-4. PubMed ID: 11452976
    [No Abstract]   [Full Text] [Related]  

  • 29. Biobusiness on campus: commercialization of university-developed biomedical technologies.
    Dueker KS
    Food Drug Law J; 1997; 52(4):453-509. PubMed ID: 10346675
    [No Abstract]   [Full Text] [Related]  

  • 30. Capitol Hill update.
    Olds JL
    Anat Rec; 1998 Feb; 253(1):3-4. PubMed ID: 9556015
    [No Abstract]   [Full Text] [Related]  

  • 31. A statesman reflects: David Korn discusses biomedical research.
    Wittenberg CK
    J Natl Cancer Inst; 1992 May; 84(9):664-6. PubMed ID: 1569594
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes in U.S. patent law for pharmaceuticals.
    Bruderle TP
    Am J Health Syst Pharm; 1995 Oct; 52(19):2088, 2091. PubMed ID: 8535940
    [No Abstract]   [Full Text] [Related]  

  • 33. Glimpses of the National Institutes of Health. I: Funding and structure.
    Smith R
    Br Med J (Clin Res Ed); 1988 Feb; 296(6622):631-4. PubMed ID: 3126931
    [No Abstract]   [Full Text] [Related]  

  • 34. Patent news.
    Steele P; Sparrowhawk M
    IDrugs; 2003 Apr; 6(4):384-5. PubMed ID: 12839016
    [No Abstract]   [Full Text] [Related]  

  • 35. H.R.7036 and the future of the N.I.H.
    Cooper T
    N Engl J Med; 1980 Nov; 303(21):1226-7. PubMed ID: 7421949
    [No Abstract]   [Full Text] [Related]  

  • 36. Sounding board. Indirect costs and the budget for the National Institutes of Health.
    Danforth WH
    N Engl J Med; 1982 Aug; 307(6):371-2. PubMed ID: 7088103
    [No Abstract]   [Full Text] [Related]  

  • 37. NIH: inside nation's top health lab.
    Carey J
    US News World Rep; 1984 Aug; 97(7):45-7. PubMed ID: 10267593
    [No Abstract]   [Full Text] [Related]  

  • 38. Health policy report. Prospects for the National Institutes of Health.
    Iglehart JK
    N Engl J Med; 1982 Apr; 306(14):879-84. PubMed ID: 7062971
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene patents.
    Nature; 1992 Oct; 359(6394):348. PubMed ID: 1406940
    [No Abstract]   [Full Text] [Related]  

  • 40. NIH is likely to challenge genetic 'probe' patents.
    Wadman M
    Nature; 1997 Mar; 386(6623):312. PubMed ID: 9121538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.